Gustavo Rivero

737 total citations
35 papers, 399 citations indexed

About

Gustavo Rivero is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Gustavo Rivero has authored 35 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 14 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Gustavo Rivero's work include Acute Myeloid Leukemia Research (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Lymphoma Diagnosis and Treatment (5 papers). Gustavo Rivero is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Lymphoma Diagnosis and Treatment (5 papers). Gustavo Rivero collaborates with scholars based in United States. Gustavo Rivero's co-authors include Dimitrios P. Kontoyiannis, Harrys A. Torres, Ray Hachem, Russell E. Lewis, Issam Raad, Richard Champlin, Hagop M. Kantarjian, Gerald P. Bodey, John Thornby and K. V. I. Rolston and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Gustavo Rivero

29 papers receiving 384 citations

Peers

Gustavo Rivero
Dimitrios P. Kontoyiannis United States
Edith Vermeulen Belgium
Takashige Miyazaki Japan
Mitra Hanisch Germany
Hansjoerg Schild Germany
Barbora Weinbergerová Czechia
Emmanuel De Laere Belgium
Katharina L. Becker Netherlands
Rachael Morris‐Jones United Kingdom
M Hotchi Japan
Dimitrios P. Kontoyiannis United States
Gustavo Rivero
Citations per year, relative to Gustavo Rivero Gustavo Rivero (= 1×) peers Dimitrios P. Kontoyiannis

Countries citing papers authored by Gustavo Rivero

Since Specialization
Citations

This map shows the geographic impact of Gustavo Rivero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gustavo Rivero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gustavo Rivero more than expected).

Fields of papers citing papers by Gustavo Rivero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gustavo Rivero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gustavo Rivero. The network helps show where Gustavo Rivero may publish in the future.

Co-authorship network of co-authors of Gustavo Rivero

This figure shows the co-authorship network connecting the top 25 collaborators of Gustavo Rivero. A scholar is included among the top collaborators of Gustavo Rivero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gustavo Rivero. Gustavo Rivero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guffey, Danielle, Rock Bum Kim, Abiodun Oluyomi, et al.. (2024). Clinical outcomes of patients with newly diagnosed large B-cell lymphoma in a safety-net hospital system. PubMed. 1(3). 100020–100020.
2.
Roth, Christine G., et al.. (2022). An Unusual Case of Breast Implant-Associated Anaplastic Large Cell Lymphoma. SHILAP Revista de lepidopterología. 2022. 1–5. 1 indexed citations
3.
Rivero, Gustavo, et al.. (2022). Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series. SHILAP Revista de lepidopterología. 4(4). 148–151. 2 indexed citations
4.
Rivero, Gustavo, et al.. (2022). Advances and Future Goals in Acute Myeloid Leukaemia Therapy. 18(2). 130–130.
5.
Chen, Yujie, et al.. (2021). Genomic trajectory in leukemogenesis of myeloproliferative neoplasms: a case report. BMC Medical Genomics. 14(1). 137–137.
6.
Sun, Yu, et al.. (2021). Hemophagocytic lymphohistiocytosis and myelodysplastic syndrome: a case report and review of the literature. Journal of Medical Case Reports. 15(1). 98–98. 2 indexed citations
7.
Abbas, Ume L., An‐Lin Cheng, Shital M. Patel, et al.. (2021). Clinical spectrum of COVID-19 and plasma angiotensin II levels. 18. 25–25.
8.
Dongarwar, Deepa, et al.. (2021). Acute Myeloid Leukemia (AML) Hospitalizations: Racial Disparity in Outcomes of Patients with Comorbidities. Blood. 138(Supplement 1). 4135–4135. 1 indexed citations
9.
Shah, Shruti & Gustavo Rivero. (2020). Higher Body Mass Index Is Associated with Differential Mutagenic Dependency in Acute Myeloid Leukemia. Blood. 136(Supplement 1). 38–40. 1 indexed citations
10.
Verstovsek, Gordana, et al.. (2020). Primary bone lymphoma of the ilium successfully treated without radiation. SHILAP Revista de lepidopterología. 8(12). 3129–3132. 1 indexed citations
11.
Snijder, J., et al.. (2019). Spontaneous remission in diffuse large cell lymphoma: a case report. Journal of Medical Case Reports. 13(1). 28–28. 14 indexed citations
12.
13.
Chang, Elaine, et al.. (2018). HIV-related Refractory Hodgkin Lymphoma: A Case Report of Complete Response to Nivolumab. Clinical Lymphoma Myeloma & Leukemia. 18(2). e143–e146. 14 indexed citations
14.
Chang, Elaine, Gustavo Rivero, Baichun Jiang, Sarvari V. Yellapragada, & Perumal Thiagarajan. (2017). Gelatinous Marrow Transformation Associated with Imatinib: Case Report and Literature Review. SHILAP Revista de lepidopterología. 2017. 1–4. 2 indexed citations
15.
16.
Li, Ang, et al.. (2012). Survival outcome of veterans with myelodysplastic syndrome (MDS) treated with statins.. Journal of Clinical Oncology. 30(15_suppl). e17018–e17018. 3 indexed citations
17.
Kontoyiannis, Dimitrios P., Ray Hachem, Russell E. Lewis, et al.. (2003). Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer. 98(2). 292–299. 223 indexed citations
18.
Rivero, Gustavo, Harrys A. Torres, K. V. I. Rolston, & Dimitrios P. Kontoyiannis. (2003). Listeria monocytogenes infection in patients with cancer. Diagnostic Microbiology and Infectious Disease. 47(2). 393–398. 40 indexed citations
19.
Torres, Harrys A., Gustavo Rivero, Russell E. Lewis, et al.. (2003). Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagnostic Microbiology and Infectious Disease. 46(1). 25–28. 46 indexed citations
20.
Torres, Harrys A., Gustavo Rivero, & Dimitrios P. Kontoyiannis. (2002). Endemic Mycoses in a Cancer Hospital. Medicine. 81(3). 201–212. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitrios P. Kontoyiannis Breakdown of academic impact, for papers by Edith Vermeulen Breakdown of academic impact, for papers by Takashige Miyazaki Breakdown of academic impact, for papers by Mitra Hanisch Breakdown of academic impact, for papers by Hansjoerg Schild Breakdown of academic impact, for papers by Barbora Weinbergerová Breakdown of academic impact, for papers by Emmanuel De Laere Breakdown of academic impact, for papers by Katharina L. Becker Breakdown of academic impact, for papers by Rachael Morris‐Jones Breakdown of academic impact, for papers by M Hotchi
Rankless by CCL
2026